Search

everythinglearnresearchcommunity

for

Search:↓

A protein called FERONIA helps control root hair growth in response to cold and low nitrogen by activating nutrient-sensing pathways in a plant called Arabidopsis.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

High mTORC1 activity slows hair growth and causes it to lose color.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

MK-5108 is safe and shows potential against tumors, especially alone.

mTORC2 is crucial for healthy skin barrier by regulating lipids and filaggrin.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Including androgens in hormone therapy may lower breast cancer risk.

Using minoxidil for hair growth may cause skin lesions in some people, and taking breaks from nitrate patches for angina might worsen symptoms.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

Minoxidil and nebivolol can help prevent aortic aging in diabetic mice.

mTORC1 activity is important for hair growth and color, and targeting it could help treat hair loss and greying.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Minoxidil protects heart and improves recovery.

Some blood pressure medications are linked to a higher risk of skin cancer.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Tadalafil and Finasteride may help treat aggressive melanoma.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.